Pro-life laws are continuing to make a MAJOR difference and save real lives since the overturn of Roe V. Wade and the latest example of this comes with one of the nation's largest pharmacy retailers.
Walgreens has decided that in 20 states with pro-life laws they will no longer allow the sale of abortion pills.
Walgreens on Friday said it will not distribute abortion medication in 20 states, bowing to pressure from anti-abortion lawmakers and lawsuits targeting the legality of medication abortion.
The company said it will not dispense mifepristone, the first of two drugs in the medication abortion process, in 20 states following a February 1 letter from GOP attorneys general in those states.
CNN is having a meltdown over the fact that in 40% of the states people can no longer conveniently kill their offspring through Walgreens pills.
"We intend to be a certified pharmacy and will distribute Mifepristone only in those jurisdictions where it is legal and operationally feasible," the company said in a statement.
It's actually stunning that a pharmacy announcing that, "hey, we're going to start obeying the law" is somehow a scandal.
Did they seriously expect them to defy the law and open themselves to all sorts of legal battles just to make lefties happy?
And the good news? It's possible it could be outlawed everywhere:
Medication abortion, which now accounts for a majority abortions obtained in the United States, has become a flashpoint in the fallout from the Supreme Court's decision last year overturning Roe v. Wade.
A federal judge in Texas is expected to rule any day on a lawsuit seeking to block the use of medication abortion nationwide, in the biggest abortion-related case since the Supreme Court overturned Roe.
The lawsuit, filed in November by anti-abortion advocates against the FDA, targets the agency's two-decade-old approval of mifepristone.
Abortion rights advocates have sounded the alarm on the case, stressing that a ruling in favor of the plaintiffs would affect every corner of the country since the lawsuit is targeting a federal agency.
"If FDA approval of mifepristone is revoked, 64.5 million women of reproductive age in the US would lose access to medication abortion care, an exponential increase in harm overnight," NARAL said in a statement in February, pointing to internal research.